Investor profile
LSP has backed 15 European tech companies across 16 funding rounds between 2016 and 2022, joining rounds totalling €650M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| DNA Script | France | 1 | €142M |
| T-knife | Germany | 1 | €93M |
| ViCentra | Netherlands | 1 | €65M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| Nouscom | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| DNA Script | Series C | €142M | 2021-10 |
| T-knife | Series B | €93M | 2021-08 |
| ViCentra | Series C | €65M | 2021-12 |
| Cardior Pharmaceuticals |
| 2 |
| €54M |
| iSTAR Medical | Belgium | 1 | €40M |
| eTheRNA | Belgium | 1 | €39M |
| OxThera | Sweden | 1 | €32M |
| Onward | Netherlands | 1 | €27M |
| G-Therapeutics | Netherlands | 1 | €26M |
| Imcheck Therapeutics | France | 1 | €20M |
| Vivasure Medical | Ireland | 1 | €16M |
| OneProjects | Ireland | 1 | €15M |
| Xeltis | Switzerland | 1 | €11M |
| Luxendo | Germany | 1 | €8.0M |
| Series B |
| €64M |
| 2021-08 |
| Nouscom | Series B | €42M | 2017-11 |
| iSTAR Medical | Series C | €40M | 2019-07 |
| eTheRNA | Series B | €39M | 2022-08 |
| OxThera | Other | €32M | 2016-11 |
| Onward | Other | €27M | 2021-04 |
| G-Therapeutics | Series A | €26M | 2016-04 |
